APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Poloxamer 338

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Poloxamer 338 Market Outlook and Growth Opportunities 2026

22 December 2025199 pages

Choose your research edition.

Industry ResearchPoloxamer 338 Industry Research Report 2026112 pages · $2,950 USDIndustry Growth & TrendsGlobal Poloxamer 338 Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal Poloxamer 338 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Poloxamer 338 Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Poloxamer 338 Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Poloxamer 338 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Poloxamer 338 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Poloxamer 338 market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Poloxamer 338 market include BASF, Croda, Comercial Química Massó and CD Formulation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Poloxamer 338 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Poloxamer 338 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Poloxamer 338 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Poloxamer 338 market size, projected growth trends, production technologies, key applications, and end-use industries.

Poloxamer 338 Segment by Company

BASF

Croda

Comercial Química Massó

CD Formulation

Poloxamer 338 Segment by Type

Purity 99%

Purity 99.9%

Others

Poloxamer 338 Segment by Application

Cosmetic

Pharmaceuticals

Others

Poloxamer 338 Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Poloxamer 338 status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Poloxamer 338 market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Poloxamer 338 significant trends, drivers, influence factors in global and regions.

6. To analyze Poloxamer 338 competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Poloxamer 338 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Poloxamer 338 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Poloxamer 338.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Poloxamer 338 market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Poloxamer 338 industry.

Chapter 3: Detailed analysis of Poloxamer 338 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Poloxamer 338 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Poloxamer 338 in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Poloxamer 338 Industry Trends Table 2. Poloxamer 338 Industry Drivers Table 3. Poloxamer 338 Industry Opportunities and Challenges Table 4. Poloxamer 338 Industry Restraints Table 5. Global Poloxamer 338 Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Poloxamer 338 Revenue Share by Company (2021-2026) Table 7. Global Poloxamer 338 Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Poloxamer 338 Sales Volume Share by Company (2021-2026) Table 9. Global Poloxamer 338 Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Poloxamer 338 Company Ranking, (2024-2026) & (USD Million) Table 11. Global Poloxamer 338 Key Company Manufacturing Base & Headquarters Table 12. Global Poloxamer 338 Company, Product Type & Application Table 13. Global Poloxamer 338 Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Poloxamer 338 by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity 99% Table 18. Significant Companies of Purity 99.9% Table 19. Significant Companies of Others Table 20. Global Poloxamer 338 Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Poloxamer 338 Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Poloxamer 338 Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Poloxamer 338 Sales Volume Share by Type (2021-2026) Table 24. Global Poloxamer 338 Sales Volume Share by Type (2027-2032) Table 25. Global Poloxamer 338 Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Poloxamer 338 Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Poloxamer 338 Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Poloxamer 338 Sales Value Share by Type (2021-2026) Table 29. Global Poloxamer 338 Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cosmetic Table 31. Significant Companies of Pharmaceuticals Table 32. Significant Companies of Others Table 33. Global Poloxamer 338 Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Poloxamer 338 Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Poloxamer 338 Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Poloxamer 338 Sales Volume Share by Application (2021-2026) Table 37. Global Poloxamer 338 Sales Volume Share by Application (2027-2032) Table 38. Global Poloxamer 338 Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Poloxamer 338 Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Poloxamer 338 Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Poloxamer 338 Sales Value Share by Application (2021-2026) Table 42. Global Poloxamer 338 Sales Value Share by Application (2027-2032) Table 43. Global Poloxamer 338 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Poloxamer 338 Sales by Region (2021-2026) & (Tons) Table 45. Global Poloxamer 338 Sales Market Share by Region (2021-2026) Table 46. Global Poloxamer 338 Sales by Region (2027-2032) & (Tons) Table 47. Global Poloxamer 338 Sales Market Share by Region (2027-2032) Table 48. Global Poloxamer 338 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Poloxamer 338 Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Poloxamer 338 Sales Value Share by Region (2021-2026) Table 51. Global Poloxamer 338 Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Poloxamer 338 Sales Value Share by Region (2027-2032) Table 53. Global Poloxamer 338 Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Poloxamer 338 Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Poloxamer 338 Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Poloxamer 338 Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Poloxamer 338 Sales by Country (2021-2026) & (Tons) Table 58. Global Poloxamer 338 Sales Market Share by Country (2021-2026) Table 59. Global Poloxamer 338 Sales by Country (2027-2032) & (Tons) Table 60. Global Poloxamer 338 Sales Market Share by Country (2027-2032) Table 61. Global Poloxamer 338 Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Poloxamer 338 Sales Value Market Share by Country (2021-2026) Table 63. Global Poloxamer 338 Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Poloxamer 338 Sales Value Market Share by Country (2027-2032) Table 65. BASF Company Information Table 66. BASF Business Overview Table 67. BASF Poloxamer 338 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. BASF Poloxamer 338 Product Portfolio Table 69. BASF Recent Development Table 70. Croda Company Information Table 71. Croda Business Overview Table 72. Croda Poloxamer 338 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Croda Poloxamer 338 Product Portfolio Table 74. Croda Recent Development Table 75. Comercial Química Massó Company Information Table 76. Comercial Química Massó Business Overview Table 77. Comercial Química Massó Poloxamer 338 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. Comercial Química Massó Poloxamer 338 Product Portfolio Table 79. Comercial Química Massó Recent Development Table 80. CD Formulation Company Information Table 81. CD Formulation Business Overview Table 82. CD Formulation Poloxamer 338 Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. CD Formulation Poloxamer 338 Product Portfolio Table 84. CD Formulation Recent Development Table 85. Key Raw Materials Table 86. Raw Materials Key Suppliers Table 87. Poloxamer 338 Distributors List Table 88. Poloxamer 338 Customers List Table 89. Research Programs/Design for This Report Table 90. Authors List of This Report Table 91. Secondary Sources Table 92. Primary Sources List of Figures Figure 1. Poloxamer 338 Product Image Figure 2. Global Poloxamer 338 Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Poloxamer 338 Sales Value (2021-2032) & (US$ Million) Figure 4. Global Poloxamer 338 Sales (2021-2032) & (Tons) Figure 5. Global Poloxamer 338 Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Poloxamer 338 Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity 99% Image Figure 10. Purity 99.9% Image Figure 11. Others Image Figure 12. Global Poloxamer 338 Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Poloxamer 338 Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Poloxamer 338 Sales Volume Share by Type (2021-2032) Figure 15. Global Poloxamer 338 Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Poloxamer 338 Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Poloxamer 338 Sales Value Share by Type (2021-2032) Figure 18. Cosmetic Image Figure 19. Pharmaceuticals Image Figure 20. Others Image Figure 21. Global Poloxamer 338 Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Poloxamer 338 Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Poloxamer 338 Sales Volume Share by Application (2021-2032) Figure 24. Global Poloxamer 338 Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Poloxamer 338 Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Poloxamer 338 Sales Value Share by Application (2021-2032) Figure 27. Global Poloxamer 338 Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Poloxamer 338 Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Poloxamer 338 Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Poloxamer 338 Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Poloxamer 338 Sales Value (2021-2032) & (US$ Million) Figure 32. North America Poloxamer 338 Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Poloxamer 338 Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Poloxamer 338 Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Poloxamer 338 Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Poloxamer 338 Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Poloxamer 338 Sales Value (2021-2032) & (US$ Million) Figure 38. South America Poloxamer 338 Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Poloxamer 338 Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Poloxamer 338 Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Poloxamer 338 Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Poloxamer 338 Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Poloxamer 338 Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Poloxamer 338 Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Poloxamer 338 Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 99%
  • Purity 99.9%
  • Others
Applications
  • Cosmetic
  • Pharmaceuticals
  • Others
Companies covered
  • BASF
  • Croda
  • Comercial Química Massó
  • CD Formulation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Poloxamer 338 Sales Value (2021-2032)
  4. 1.2.2 Global Poloxamer 338 Sales Volume (2021-2032)
  5. 1.2.3 Global Poloxamer 338 Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Poloxamer 338 Market Dynamics
  1. 2.1 Poloxamer 338 Industry Trends
  2. 2.2 Poloxamer 338 Industry Drivers
  3. 2.3 Poloxamer 338 Industry Opportunities and Challenges
  4. 2.4 Poloxamer 338 Industry Restraints
3 Poloxamer 338 Market by Company
  1. 3.1 Global Poloxamer 338 Company Revenue Ranking in 2025
  2. 3.2 Global Poloxamer 338 Revenue by Company (2021-2026)
  3. 3.3 Global Poloxamer 338 Sales Volume by Company (2021-2026)
  4. 3.4 Global Poloxamer 338 Average Price by Company (2021-2026)
  5. 3.5 Global Poloxamer 338 Company Ranking (2024-2026)
  6. 3.6 Global Poloxamer 338 Company Manufacturing Base and Headquarters
  7. 3.7 Global Poloxamer 338 Company Product Type and Application
  8. 3.8 Global Poloxamer 338 Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Poloxamer 338 Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Poloxamer 338 Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Poloxamer 338 Market by Type
  1. 4.1 Poloxamer 338 Type Introduction
  2. 4.1.1 Purity 99%
  3. 4.1.2 Purity 99.9%
  4. 4.1.3 Others
  5. 4.2 Global Poloxamer 338 Sales Volume by Type
  6. 4.2.1 Global Poloxamer 338 Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Poloxamer 338 Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Poloxamer 338 Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Poloxamer 338 Sales Value by Type
  10. 4.3.1 Global Poloxamer 338 Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Poloxamer 338 Sales Value by Type (2021-2032)
  12. 4.3.3 Global Poloxamer 338 Sales Value Share by Type (2021-2032)
5 Poloxamer 338 Market by Application
  1. 5.1 Poloxamer 338 Application Introduction
  2. 5.1.1 Cosmetic
  3. 5.1.2 Pharmaceuticals
  4. 5.1.3 Others
  5. 5.2 Global Poloxamer 338 Sales Volume by Application
  6. 5.2.1 Global Poloxamer 338 Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Poloxamer 338 Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Poloxamer 338 Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Poloxamer 338 Sales Value by Application
  10. 5.3.1 Global Poloxamer 338 Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Poloxamer 338 Sales Value by Application (2021-2032)
  12. 5.3.3 Global Poloxamer 338 Sales Value Share by Application (2021-2032)
6 Poloxamer 338 Regional Sales and Value Analysis
  1. 6.1 Global Poloxamer 338 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Poloxamer 338 Sales by Region (2021-2032)
  3. 6.2.1 Global Poloxamer 338 Sales by Region: 2021-2026
  4. 6.2.2 Global Poloxamer 338 Sales by Region (2027-2032)
  5. 6.3 Global Poloxamer 338 Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Poloxamer 338 Sales Value by Region (2021-2032)
  7. 6.4.1 Global Poloxamer 338 Sales Value by Region: 2021-2026
  8. 6.4.2 Global Poloxamer 338 Sales Value by Region (2027-2032)
  9. 6.5 Global Poloxamer 338 Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Poloxamer 338 Sales Value (2021-2032)
  12. 6.6.2 North America Poloxamer 338 Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Poloxamer 338 Sales Value (2021-2032)
  15. 6.7.2 Europe Poloxamer 338 Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Poloxamer 338 Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Poloxamer 338 Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Poloxamer 338 Sales Value (2021-2032)
  21. 6.9.2 South America Poloxamer 338 Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Poloxamer 338 Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Poloxamer 338 Sales Value Share by Country, 2025 VS 2032
7 Poloxamer 338 Country-level Sales and Value Analysis
  1. 7.1 Global Poloxamer 338 Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Poloxamer 338 Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Poloxamer 338 Sales by Country (2021-2032)
  4. 7.3.1 Global Poloxamer 338 Sales by Country (2021-2026)
  5. 7.3.2 Global Poloxamer 338 Sales by Country (2027-2032)
  6. 7.4 Global Poloxamer 338 Sales Value by Country (2021-2032)
  7. 7.4.1 Global Poloxamer 338 Sales Value by Country (2021-2026)
  8. 7.4.2 Global Poloxamer 338 Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Poloxamer 338 Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Poloxamer 338 Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Poloxamer 338 Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Poloxamer 338 Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Poloxamer 338 Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Poloxamer 338 Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Poloxamer 338 Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Poloxamer 338 Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Poloxamer 338 Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Poloxamer 338 Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Poloxamer 338 Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Poloxamer 338 Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Poloxamer 338 Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Poloxamer 338 Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Poloxamer 338 Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Poloxamer 338 Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Poloxamer 338 Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Poloxamer 338 Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Poloxamer 338 Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Poloxamer 338 Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Poloxamer 338 Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Poloxamer 338 Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Poloxamer 338 Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Poloxamer 338 Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Poloxamer 338 Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Poloxamer 338 Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Poloxamer 338 Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Poloxamer 338 Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Poloxamer 338 Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Poloxamer 338 Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 BASF
  2. 8.1.1 BASF Company Information
  3. 8.1.2 BASF Business Overview
  4. 8.1.3 BASF Poloxamer 338 Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 BASF Poloxamer 338 Product Portfolio
  6. 8.1.5 BASF Recent Developments
  7. 8.2 Croda
  8. 8.2.1 Croda Company Information
  9. 8.2.2 Croda Business Overview
  10. 8.2.3 Croda Poloxamer 338 Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Croda Poloxamer 338 Product Portfolio
  12. 8.2.5 Croda Recent Developments
  13. 8.3 Comercial Química Massó
  14. 8.3.1 Comercial Química Massó Company Information
  15. 8.3.2 Comercial Química Massó Business Overview
  16. 8.3.3 Comercial Química Massó Poloxamer 338 Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Comercial Química Massó Poloxamer 338 Product Portfolio
  18. 8.3.5 Comercial Química Massó Recent Developments
  19. 8.4 CD Formulation
  20. 8.4.1 CD Formulation Company Information
  21. 8.4.2 CD Formulation Business Overview
  22. 8.4.3 CD Formulation Poloxamer 338 Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 CD Formulation Poloxamer 338 Product Portfolio
  24. 8.4.5 CD Formulation Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Poloxamer 338 Value Chain Analysis
  2. 9.1.1 Poloxamer 338 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Poloxamer 338 Sales Mode & Process
  6. 9.2 Poloxamer 338 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Poloxamer 338 Distributors
  9. 9.2.3 Poloxamer 338 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst